- Report
- July 2023
- 105 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Book
- November 2009
- 384 Pages
Asparaginase is a type of drug used to treat leukemia, a type of cancer. It works by breaking down the amino acid asparagine, which is essential for the growth of cancer cells. Asparaginase is used in combination with other chemotherapy drugs to treat acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It is also used to treat non-Hodgkin's lymphoma and other types of cancer. Asparaginase is available in both injectable and oral forms. The injectable form is usually given intravenously, while the oral form is taken as a pill.
The asparaginase market is highly competitive, with several companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Other companies include Amgen, Teva Pharmaceuticals, and Eli Lilly. Show Less Read more